INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,669 Cr | ₹1,541 Cr | ₹1,242 Cr | ₹1,107 Cr | ₹968 Cr |
What is the latest Revenue of INDOCO REMEDIES ?
Year | Revenue |
---|---|
Mar2024 | ₹1,669 Cr |
Mar2023 | ₹1,541 Cr |
Mar2022 | ₹1,242 Cr |
Mar2021 | ₹1,107 Cr |
Mar2020 | ₹968 Cr |
How is Revenue of INDOCO REMEDIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,669 Cr | 8.30 | |
Mar2023 | ₹1,541 Cr | 24.10 | |
Mar2022 | ₹1,242 Cr | 12.19 | |
Mar2021 | ₹1,107 Cr | 14.26 | |
Mar2020 | ₹968 Cr | - |
Compare Revenue of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹2,858.7 Cr | -8.2% | 9.9% | -3.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,712.0 Cr | -1.3% | 1% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,623.0 Cr | -3.2% | -0.3% | 48% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,285.0 Cr | 1.2% | 10.7% | 19.5% | Stock Analytics | |
CIPLA | ₹119,010.0 Cr | -0.6% | -2.2% | -0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,118.0 Cr | -1.5% | -5.9% | -5.1% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | -8.2% |
9.9% |
-3.4% |
SENSEX | 0.1% |
1% |
2.6% |
You may also like the below Video Courses